New application of β-galactosidase complementation to monitor tau self-association

Journal of Neurochemistry

Volumn 106, Issue 4, 2008, Pages 1545-1551

  Ding, Huiping ^b   Johnson, Gail V W ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

galactosidase activity; Alzheimer's disease; Lithium; Tangles; Tau tau interactions

Indexed keywords

BETA GALACTOSIDASE; LITHIUM; POLYACRYLAMIDE GEL; SUBERIC ACID BIS(N HYDROXYSUCCINIMIDE) ESTER; SUCCINIC ACID DERIVATIVE; TAU PROTEIN;

ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CROSS LINKING; EMBRYO; ENZYME ACTIVITY; HISTOCHEMISTRY; HUMAN; HUMAN CELL; KIDNEY CELL; MUTANT; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN PROTEIN INTERACTION;

BETA-GALACTOSIDASE; CELL LINE; GENETIC COMPLEMENTATION TEST; HUMANS; NEUROFIBRILLARY TANGLES; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; TAU PROTEINS;

EID: 48749126438     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05496.x     Document Type: Article

References (33)

1. Alonso A. C., Zaidi T., Grundke-Iqbal I. Iqbal K. (1994) Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc. Natl Acad. Sci. USA 91, 5562 5566.
2. Alonso A., Zaidi T., Novak M., Grundke-Iqbal I. Iqbal K. (2001) Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc. Natl Acad. Sci. USA 98, 6923 6928.
3. Andorfer C., Kress Y., Espinoza M., de Silva R., Tucker K. L., Barde Y. A., Duff K. Davies P. (2003) Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. J. Neurochem. 86, 582 590.
4. von Bergen M., Barghorn S., Biernat J., Mandelkow E. M. Mandelkow E. (2005) Tau aggregation is driven by a transition from random coil to beta sheet structure. Biochim. Biophys. Acta 1739, 158 166.
5. Blakely B. T., Rossi F. M., Tillotson B., Palmer M., Estelles A. Blau H. M. (2000) Epidermal growth factor receptor dimerization monitored in live cells. Nat. Biotechnol. 18, 218 222.
6. Buensuceso C., de Virgilio M. Shattil S. J. (2003) Detection of integrin alpha IIbbeta 3 clustering in living cells. J. Biol. Chem. 278, 15217 15224.
7. Caccamo A., Oddo S., Tran L. X. LaFerla F. M. (2007) Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles. Am. J. Pathol. 170, 1669 1675.
8. Cho J. H. Johnson G. V. (2003) Glycogen synthase kinase 3beta phosphorylates tau at both primed and unprimed sites. Differential impact on microtubule binding. J. Biol. Chem. 278, 187 193.
9. Cho J. H. Johnson G. V. (2004) Glycogen synthase kinase 3 beta induces caspase-cleaved tau aggregation in situ. J. Biol. Chem. 279, 54716 54723.
10. Chun W. Johnson G. V. (2007) Activation of glycogen synthase kinase 3beta promotes the intermolecular association of tau. The use of fluorescence resonance energy transfer microscopy. J. Biol. Chem. 282, 23410 23417.
11. DeTure M., Ko L. W., Easson C. Yen S. H. (2002) Tau assembly in inducible transfectants expressing wild-type or FTDP-17 tau. Am. J. Pathol. 161, 1711 1722.
12. Ding H., Matthews T. A. Johnson G. V. (2006) Site-specific phosphorylation and caspase cleavage differentially impact tau-microtubule interactions and tau aggregation. J. Biol. Chem. 281, 19107 19114.
13. Ferrari A., Hoerndli F., Baechi T., Nitsch R. M. Gotz J. (2003) beta-Amyloid induces paired helical filament-like tau filaments in tissue culture. J. Biol. Chem. 278, 40162 40168.
14. Gamblin T. C., Berry R. W. Binder L. I. (2003a) Modeling tau polymerization in vitro: a review and synthesis. Biochemistry 42, 15009 15017.
15. Gamblin T. C., Chen F., Zambrano A. et al. (2003b) Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc. Natl Acad. Sci. USA 100, 10032 10037.
16. Grober E., Dickson D., Sliwinski M. J., Buschke H., Katz M., Crystal H. Lipton R. B. (1999) Memory and mental status correlates of modified Braak staging. Neurobiol. Aging 20, 573 579.
17. Grundke-Iqbal I., Iqbal K., Tung Y. C., Quinlan M., Wisniewski H. M. Binder L. I. (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl Acad. Sci. USA 83, 4913 4917.
18. Hong M., Chen D. C., Klein P. S. Lee V. M. (1997) Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. J. Biol. Chem. 272, 25326 25332.
19. Johnson G. V. Bailey C. D. (2002) Tau, where are we now? J Alzheimers Dis. 4, 375 398.
20. Kosik K. S., Joachim C. L. Selkoe D. J. (1986) Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl Acad. Sci. USA 83, 4044 4048.
21. Langley K. E. Zabin I. (1976) beta-Galactosidase alpha complementation: properties of the complemented enzyme and mechanism of the complementation reaction. Biochemistry 15, 4866 4875.
22. Le Corre S., Klafki H. W., Plesnila N. et al. (2006) An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice. Proc. Natl Acad. Sci. USA 103, 9673 9678.
23. Matthews B. W. (2005) The structure of E. coli beta-galactosidase. C. R. Biol. 328, 549 556.
24. Mazanetz M. P. Fischer P. M. (2007) Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases. Nat. Rev. Drug Discov. 6, 464 479.
25. Mohler W. A. Blau H. M. (1996) Gene expression and cell fusion analyzed by lacZ complementation in mammalian cells. Proc. Natl Acad. Sci. USA 93, 12423 12427.
26. Noble W., Planel E., Zehr C. et al. (2005) Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc. Natl Acad. Sci. USA 102, 6990 6995.
27. Rissman R. A., Poon W. W., Blurton-Jones M., Oddo S., Torp R., Vitek M. P., LaFerla F. M., Rohn T. T. Cotman C. W. (2004) Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. J. Clin. Invest. 114, 121 130.
28. Roberson E. D., Scearce-Levie K., Palop J. J., Yan F., Cheng I. H., Wu T., Gerstein H., Yu G. Q. Mucke L. (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316, 750 754.
29. Rossi F., Charlton C. A. Blau H. M. (1997) Monitoring protein-protein interactions in intact eukaryotic cells by beta-galactosidase complementation. Proc. Natl Acad. Sci. USA 94, 8405 8410.
30. Santacruz K., Lewis J., Spires T. et al. (2005) Tau suppression in a neurodegenerative mouse model improves memory function. Science 309, 476 481.
31. Wittmann C. W., Wszolek M. F., Shulman J. M., Salvaterra P. M., Lewis J., Hutton M. Feany M. B. (2001) Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 293, 711 714.
32. Yan Y. X., Boldt-Houle D. M., Tillotson B. P., Gee M. A., D'Eon B. J., Chang X. J., Olesen C. E. Palmer M. A. (2002) Cell-based high-throughput screening assay system for monitoring G protein-coupled receptor activation using beta-galactosidase enzyme complementation technology. J. Biomol. Screen 7, 451 459.
33. Yin H. Kuret J. (2006) C-terminal truncation modulates both nucleation and extension phases of tau fibrillization. FEBS Lett. 580, 211 215.